surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, surmount-1 tirzepatide non-diabetic obesity trial

On May 18, 2026, PSM sent a letter rebuking the Arkansas Democrat-Gazette for selling ad space to a Canadian online pharmacy last month

The cohort study of over 16,000 patients found that patients taking semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), who had type 2 diabetes or were overweight, had an increased risk of NAION and other vision problems

Notably, glutathione-S-transferase (GST) does not appear to be considerably increased due to maternal cigarette smoking [101,102,103,121,122], whereas UDP-glucuronosyltransferase (UGT) activity is stimulated by both cigarette smoking and alcohol intake [124,125]

Kennedy Jr., whom President-elect Donald Trump tapped to lead the Department of Health and Human Services, has shared his disapproval of the drugs popularity

Final co-pay costs may be not be known until medication pick-up at the pharmacy

Effects of Isolated Soluble Fiber Supplementation on Body Weight, Glycemia, and Insulinemia in Adults With Overweight and Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials